Alkali Metals Ltd

Alkali Metals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Alkali Metals Ltd

₹ 92.8 -2.23%
04 Jun - close price
alkalimetals.com BSE: 533029 NSE: ALKALI
About

Incorporated in 1968, Alkali Metals Ltd is a manufacturer of Sodium Derivatives, Pyridine Derivatives, Fine Chemicals and APIs etc.[1]

Key Points

Business Overview:[1]
AML, originally a joint venture with Andhra Pradesh Industrial Development Corporation Limited (APIDCL), is now an ISO 9001 & 14001-certified manufacturer specializing in sodium metal derivatives, picoline-based compounds, and cyclic chemicals. Its key products include sodium amide, sodium azide, sodium hydride, amino pyridines, fine chemicals, and APIs, primarily supplied to pharmaceutical companies for bulk drug production

Website BSE NSE - BE
  • Market Cap ₹ 94.5 Cr.
  • Current Price ₹ 92.8
  • High / Low ₹ 110 / 46.8
  • Stock P/E 169
  • Book Value ₹ 43.9
  • Dividend Yield 0.54 %
  • ROCE 8.69 %
  • ROE 1.26 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • The company has delivered a poor sales growth of 10.9% over past five years.
  • Company has a low return on equity of -1.04% over last 3 years.
  • Promoters have pledged 30.1% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
26.90 17.05 16.84 24.55 24.42 14.67 20.46 22.34 24.87 20.61 18.77 24.91 28.73
23.60 15.28 15.11 21.78 22.53 16.40 20.69 24.29 21.70 19.06 18.59 25.17 22.65
Operating Profit 3.30 1.77 1.73 2.77 1.89 -1.73 -0.23 -1.95 3.17 1.55 0.18 -0.26 6.08
OPM % 12.27% 10.38% 10.27% 11.28% 7.74% -11.79% -1.12% -8.73% 12.75% 7.52% 0.96% -1.04% 21.16%
0.23 0.08 0.20 0.10 0.17 0.08 0.10 -1.21 0.28 0.04 0.05 0.24 0.28
Interest 1.18 0.61 0.69 0.75 0.51 0.58 0.80 0.50 0.52 0.44 0.42 0.69 0.40
Depreciation 1.10 1.13 1.15 1.17 1.15 1.09 1.08 1.08 0.90 0.82 0.72 0.68 0.66
Profit before tax 1.25 0.11 0.09 0.95 0.40 -3.32 -2.01 -4.74 2.03 0.33 -0.91 -1.39 5.30
Tax % 21.60% 0.00% 0.00% 62.11% -42.50% 0.00% -5.47% 4.22% -114.29% 448.48% 0.00% 0.00% 24.15%
0.98 0.11 0.10 0.36 0.56 -3.32 -1.90 -4.93 4.35 -1.15 -0.91 -1.39 4.02
EPS in Rs 0.96 0.11 0.10 0.35 0.55 -3.26 -1.87 -4.84 4.27 -1.13 -0.89 -1.37 3.95
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
68.44 73.28 61.12 64.93 71.56 70.85 55.38 91.02 88.23 82.86 82.33 93.03
59.01 63.35 54.28 58.13 64.14 64.17 49.32 79.64 78.55 74.57 83.07 85.31
Operating Profit 9.43 9.93 6.84 6.80 7.42 6.68 6.06 11.38 9.68 8.29 -0.74 7.72
OPM % 13.78% 13.55% 11.19% 10.47% 10.37% 9.43% 10.94% 12.50% 10.97% 10.00% -0.90% 8.30%
-0.35 0.25 0.12 0.50 0.40 0.35 0.05 0.14 1.05 0.42 -0.75 0.61
Interest 4.50 3.44 2.96 2.52 2.71 2.47 2.54 2.63 2.67 2.56 2.40 2.13
Depreciation 4.27 3.75 3.62 3.48 3.41 3.45 3.35 3.86 4.29 4.60 4.15 2.89
Profit before tax 0.31 2.99 0.38 1.30 1.70 1.11 0.22 5.03 3.77 1.55 -8.04 3.31
Tax % 6.45% 24.41% 7.89% 0.00% 0.00% -12.61% 650.00% 30.82% 22.55% 27.10% -27.86% 83.38%
0.28 2.26 0.35 1.31 1.69 1.25 -1.21 3.48 2.91 1.13 -5.80 0.56
EPS in Rs 0.27 2.22 0.34 1.29 1.66 1.23 -1.19 3.42 2.86 1.11 -5.70 0.55
Dividend Payout % 0.00% 54.05% 145.43% 77.71% 72.28% 81.44% -67.31% 58.51% 69.97% 90.09% -8.78% 0.00%
Compounded Sales Growth
10 Years: 2%
5 Years: 11%
3 Years: 2%
TTM: 13%
Compounded Profit Growth
10 Years: -13%
5 Years: 18%
3 Years: -43%
TTM: 116%
Stock Price CAGR
10 Years: 5%
5 Years: 6%
3 Years: -6%
1 Year: -9%
Return on Equity
10 Years: 2%
5 Years: 2%
3 Years: -1%
Last Year: 1%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 10.18 10.18 10.18 10.18 10.18 10.18 10.18 10.18 10.18 10.18 10.18 10.18
Reserves 39.19 39.97 40.34 41.20 41.85 40.10 39.19 41.90 42.68 41.16 34.34 34.51
32.75 21.69 21.44 18.08 18.19 19.99 21.92 17.25 23.82 22.84 18.18 17.85
12.47 15.14 17.55 19.46 20.81 16.98 24.96 27.42 25.24 31.33 28.39 33.01
Total Liabilities 94.59 86.98 89.51 88.92 91.03 87.25 96.25 96.75 101.92 105.51 91.09 95.55
57.00 53.71 49.84 46.82 44.76 44.87 46.66 46.27 49.47 47.29 41.03 38.46
CWIP 0.36 0.46 1.56 1.55 2.12 2.15 0.43 0.63 1.33 0.19 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
37.23 32.81 38.11 40.55 44.15 40.23 49.16 49.85 51.12 58.03 50.06 57.09
Total Assets 94.59 86.98 89.51 88.92 91.03 87.25 96.25 96.75 101.92 105.51 91.09 95.55

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
9.16 8.28 4.19 4.50 6.90 9.43 1.32 11.19 11.19 6.29 5.44 2.82
-2.11 -0.44 -0.97 -0.41 -2.81 -3.74 -3.52 -2.84 -3.14 -1.64 -0.75 -0.27
-5.53 -9.92 -3.26 -4.06 -4.08 -3.16 0.07 -6.82 -8.96 -5.71 -4.69 -2.54
Net Cash Flow 1.52 -2.08 -0.05 0.03 0.02 2.53 -2.13 1.53 -0.91 -1.06 0.00 0.01
Free Cash Flow 6.83 7.72 3.05 4.01 3.99 5.63 -2.24 8.33 8.05 4.60 4.62 2.50
CFO/OP 97% 94% 65% 62% 92% 145% 23% 94% 116% 76% -735% 37%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 45.65 56.28 61.39 79.26 54.78 32.82 79.02 53.74 56.63 79.16 63.57 76.15
Inventory Days 176.18 119.11 251.90 194.18 241.56 233.58 493.80 245.90 277.93 381.69 223.28 223.59
Days Payable 111.92 116.85 182.90 166.75 169.77 121.63 318.70 165.04 180.30 281.00 161.04 203.67
Cash Conversion Cycle 109.91 58.55 130.39 106.70 126.57 144.76 254.13 134.59 154.26 179.84 125.82 96.08
Working Capital Days -13.01 -24.01 -9.50 7.65 14.69 5.31 48.57 25.91 20.52 31.50 1.37 20.48
ROCE % 6.97% 8.35% 5.05% 5.47% 6.31% 5.41% 4.10% 11.11% 8.94% 5.99% -4.87% 8.69%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2027 (P)
Average Capacity Utilization of Working Capital Limits
%

Log in to view insights

Please log in to see hidden values.

Login
Finished Products Sales Volume
MT
Number of Permanent Employees
Number
Global Market Share for 2 Nitro 5 Bromopyridine
%
Target Number of Countries for Presence
Number
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
69.59% 69.59% 69.59% 69.59% 69.59% 69.59% 69.59% 69.59% 69.59% 69.59% 69.59% 69.59%
0.44% 0.41% 0.12% 0.16% 0.07% 0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
29.98% 30.00% 30.30% 30.26% 30.34% 30.35% 30.42% 30.41% 30.41% 30.41% 30.42% 30.41%
No. of Shareholders 13,53113,18512,20812,29512,56613,73013,60113,48713,52213,28013,06512,906

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings